Products
Products
< Back
JC200

Model JC200 Focused Ultrasound Tumor Therapeutic System

Non-invasive, extracorporeal ultrasound ablation treatment of tumors


Download the brochure of JC200

Indications

Solid tumors of all types of soft tissues such as:

Benign:

Benign gynecologic tumors such as uterine fibroids

Malignant:

? liver tumors
? bone tumors
? breast tumors
? fibroadenoma of breast


Contraindications
?  Tumor of head 
?  Tumor in spine and vertebral canal 
?  Tumor of gastrointestinal tract
?  Tumor in thoracic cavity 
?  Tumor of hollow viscous with obstruction


Clinical Advangtages
? Noninvasive treatment to preserve organs and structures, with no blood transfusion and no radiation
? Conformal and precise ablation
? One time treatment, no limitation by tumor size and shape
? Real-time ultrasound-guided therapy with digital quantitative analysis
? Activation of immune system


Approvals: Europe: CE, China: CFDA



Package Price: three million and two hundred thousand US dollars ($3,200,000) to three million and nine hundred thousand US dollars ($3,900,000), including: 

1. The commodity of Model JC200 Focused Ultrasound Tumor Therapeutic System
2. HIFU doctor training
3. On-site clinical support
4. One (1) to five (5) years of guarantee and maintenance of the commodity
5. One (1) to five (5) years of clinical service via telemedicine center
6. One (1) to five (5) years of engineering service via telemedicine center
7. Five (5) years of software upgrade
国产Aⅴ无码专区亚洲AV